Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1995-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.39.4.910PMID 7785994PMCID PMC162652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627

  2005cited by this paper
• Binding affinities of β-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus

  1995cited by this paper
• Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane

  1993cited by this paper
• In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity

  1993cited by this paper
• Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

  1992cited by this paper
• Structure-activity relationships of carbapenem and penem compounds for the convulsive property.

  1992cited by this paper
• In vitro activity of L-627, a new carbapenem

  1992cited by this paper
• In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I

  1990cited by this paper
• Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus

  1990cited by this paper
• In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338

  1989cited by this paper
• In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

  1989cited by this paper
• In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem

  1986cited by this paper
• Characterization of an isogenic set of methicillin-resistant and susceptible mutants ofStaphylococcus aureus

  1986cited by this paper
• Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks.

  1982cited by this paper
• The emergence of methicillin-resistant Staphylococcus aureus.

  1982cited by this paper
• Properties of the penicillin-binding proteins of Escherichia coli K12,.

  1977cited by this paper
• Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.

  1973cited by this paper
• Estimation of the ED50 and Its Error by Means of Logarithmic-Probit Graph Paper.∗

  1944cited by this paper

• CTX-M class of ESBLs

  2011cites this paper
• beta-lactams vs. beta-lactamases - recent evolution of concurrent occurrence of multiple bla genes including blaCTX-M and blaampC: an Indian scenario

  2011cites this paper
• Current status of newer carbapenems.

  2009cites this paper
• Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

  2009influential citation
• CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.

  2007cites this paper
• Beta-lactams against methicillin-resistant Staphylococcus aureus.

  2005cites this paper
• Evaluation of Ceftobiprole in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus

  2005cites this paper
• In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem

  2005cites this paper
• SM-216601, a Novel Parenteral 1β-Methylcarbapenem: Structure-activity Relationships of Antibacterial Activity and Neurotoxicity in Mice

  2005cites this paper
• The Leptomycin Gene Cluster and Its Heterologous Expression in Streptomyces lividans

  2005cites this paper
• The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

  2004cites this paper
• PBP 2a Mutations Producing Very-High-Level Resistance to Beta-Lactams

  2004cites this paper
• Solving staphylococcal resistance to β-lactams

  2003cites this paper
• The Art of Fusion: From Penams and Cephems to Penems

  2003cites this paper
• In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.

  2003cites this paper
• In Vitro and In Vivo Activities of Novel 2-(Thiazol-2-ylthio)-1 (cid:2) -Methylcarbapenems with Potent Activities against Multiresistant Gram-Positive Bacteria

  2003cites this paper
• Solving staphylococcal resistance to beta-lactams.

  2003cites this paper
• In Vitro and In Vivo Activities of Novel 2-(Thiazol-2-ylthio)-1β-Methylcarbapenems with Potent Activities against Multiresistant Gram-Positive Bacteria

  2003cites this paper
• New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.

  2002cites this paper
• CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa

  2002cites this paper
• In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.

  2002influential citation
• In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci

  2001influential citation
• Synthesis of J-111,347, a novel 1 beta-methylcarbapenem with broad-spectrum antibacterial activity.

  2000cites this paper
• In Vitro Activities of Noveltrans-3,5-Disubstituted Pyrrolidinylthio-1β-Methylcarbapenems with Potent Activities against Methicillin-Resistant Staphylococcus aureus andPseudomonas aeruginosa

  2000cites this paper
• MRSA and MRSE: is there an answer?

  2000cites this paper
• Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections?

  2000cites this paper
• Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenem, against experimental murine systemic infections.

  2000cites this paper
• Synthesis and biological evaluation of novel tricyclic carbapenems (trinems).

  2000cites this paper
• Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compounds.

  2000cites this paper
• Structure–activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Part 1: J-111,347 and related compounds

  2000cites this paper
• In Vitro Activities of Novel trans -3,5-Disubstituted Pyrrolidinylthio-1 b -Methylcarbapenems with Potent Activities against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa

  2000cites this paper
• Antibiotic resistance versus small molecules, the chemical evolution

  1999cites this paper
• Antibiotic resistance: a current perspective.

  1999cites this paper
• Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections.

  1998cites this paper
• Novel anti-staphylococcal targets and compounds.

  1998cites this paper
• Recent advances in carbapenem chemistry (review)

  1998cites this paper
• New trends in antimicrobial development.

  1998cites this paper
• New Trends in Antimicrobial Development

  1998cites this paper
• Leading articles The renaissance of antibody therapy

  1998cites this paper
• Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications

  1997cites this paper
• 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.

  1997cites this paper
• The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

  1997cites this paper
• Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.

  1997cites this paper
• In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci

  1997cites this paper
• Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus

  1997cites this paper
• Novel dithiocarbamate carbapenems with anti-MRSA activity.

  1997cites this paper
• New directions in antibacterial research.

  1996cites this paper
• Drug-resistant staphylococcal infections*

  1996cites this paper
• Chapter 13. Antibacterial Agents

  1996cites this paper